Director · Mineralys Therapeutics, Inc. · Mineralys Therapeutics, Inc. — Stock Option
Side
M
Value
—
Shares
3,000
Price
—
Executed
Jun 17, 2026
Disclosed
Jun 17, 2026
Disclosure timeline0 days from execution to publication · legal deadline 2 business days
Jun 17 executedJun 17, 2026 disclosed
MLYS · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Option exercise — administrative, little informational value
Relative size+5 / 25
No reported dollar value · 8.6% of prior position
Filing timing0 / 15
Disclosed 0 business days after execution (deadline: 2)
Historical behavior+4 / 15
2 prior trades recorded in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
Pre-arranged plan-10
Executed under a Rule 10b5-1 trading plan
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Karydas Daphne filed this Form 4 reporting a option exercise of MLYS on Jun 17, 2026. It became public on Jun 17, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director
Karydas Daphnecik:0001816952
Issuer
Mineralys Therapeutics, Inc.cik:0001933414
Revision history · 0
No field has changed since this record was first ingested.
